INS and diabetes mellitus: The restoration of deficient β-cell mass by transplantation from exogenous sources or by endogenous regeneration of insulin-producing cells would undoubtedly be a worthwhile therapeutic goal that will significantly ameliorate diabetes and its complications [17, 18].